Nobis Nobis Cartel windows 7 home premium activation key
블로그 보관소

Rituximab in pemphigus

Pemphigus is a chronic, muco-cutaneous autoimmune blistering disorder; two main variants being pemphigus vulgaris (PV) and pemphigus foliaceus (PF). PV is the most common subtype, varying between 75 to 92% of total pemphigus patients. Although no community based studies are undertaken

태그됨: , , , , , , , ,
전세계, 뉴스 및 정보 에 올린 글

Pemphigus: An Ayurvedic Approach

By Jay Glaser, M.D. Dr. Glaser is a board-certified internist, researcher and medical director at the Lancaster Ayurveda Medical Centers based in Sterling, MA. He can be reached at 978-422-5044. Answers to many questions about Ayurveda can be found on

태그됨: , , , , , , ,
의료 에 올린 글

Steroid-Induced Diabetes

by Christopher D. Saudek, M.D., Professor of Medicine, Johns Hopkins University School of Medicine, President, American Diabetes Association (July 2001). Steroids are commonly used in medicine, and their effects on blood sugar are often seriously underestimated. To give the bottom

태그됨: , ,
의료 에 올린 글

New Perspectives on the Cause of Blister Formation

By Sergei A. Grando, M.D., Ph.D., D.Sci. Professor of Dermatology University of California Davis NPF Advisory Board Member The goal of my research is to develop a safer and more rational treatment for pemphigus. I am deeply concerned that we,

태그됨: , , , , , , ,
의료 에 올린 글

Cellcept: A Promising New Immunosuppressive Drug

By Grant J. Anhalt, M.D. and Hossein Nousari, M.D.Johns Hopkins University, School of Medicine In February 1997, the FDA approved a new drug, mycophenolate mofetil (MFM, also known as Cellcept) with an approved indication for use in immunosuppression of patients

태그됨: , , , , , , ,
의료 에 올린 글

Bullous Disease Treatment

Grant J. Anhalt, MD Head, Dermatoimmunology Department Johns Hopkins University Baltimore, Maryland Vice President in charge of Scientific Affairs, The International Pemphigus Foundation

Prior to the introduction of an effective therapy with oral corticosteroids in the 1950s, the disease had a dismal natural course with a 50% mortality rate at 2 years and 100%

태그됨: , , , , , , , ,
의료 에 올린 글

오늘 가입!

P/P 레지스트리 서쪽 기관 검토 위원회에 의해 승인 되었습니다. (WIRB) 그리고 적극적으로 등록 하는 참가자는.

영어 버전